Related Experiment Video
Updated: May 19, 2026

Immunostaining-Based Detection of Dynamic Alterations in Red Blood Cell Proteins
Published on: March 17, 2023
Calpain-1 knockout reveals broad effects on erythrocyte deformability and physiology
Adam Wieschhaus1, Anwar Khan, Asma Zaidi
1Department of Molecular Physiology and Pharmacology, Tufts University School of Medicine, Boston, MA 02111, USA.
Insights
Calpain-1 deficiency improves red blood cell (RBC) deformability by preventing cytoskeletal protein degradation, impacting ion transport and offering potential therapeutic avenues for calcium imbalance disorders.
Area of Science:
- Hematology
- Cell Biology
- Biochemistry
Background:
- Calpain activity in erythrocytes is poorly understood despite pharmacological insights.
- Erythrocytes express calpain-1, regulated by its endogenous inhibitor, calpastatin.
Purpose of the Study:
- Investigate the physiological function of calpain-1 in mature erythrocytes.
- Utilize a calpain-1-null (KO) mouse model to elucidate calpain-1's role.
Main Methods:
- Generated and analyzed calpain-1 knockout (KO) erythrocytes.
- Assessed erythrocyte deformability, shape transition, membrane protein integrity, and ion transporter activity.
- Utilized atomic force microscopy to analyze the skeletal network.
Main Results:
- Calpain-1 deletion improved erythrocyte deformability without affecting lifespan.
- Calcium-induced shape changes were impaired, and key membrane proteins were protected from degradation in KO erythrocytes.
- Reduced activity of K+-Cl- cotransporter and Gardos channel observed in KO erythrocytes.
- Altered basal and calmodulin-stimulated calcium pump activity noted in KO erythrocytes.
Conclusions:
- Calpain-1 plays a crucial role in erythrocyte cytoskeletal remodeling and ion transport.
- Findings provide the first evidence for calpain-1's physiological function in erythrocytes.
- Potential therapeutic implications for calcium imbalance disorders like sickle cell disease.
Abstract:
Pharmacological inhibitors of cysteine proteases have provided useful insights into the regulation of calpain activity in erythrocytes. However, the precise biological function of calpain activity in erythrocytes remains poorly understood. Erythrocytes express calpain-1, an isoform regulated by calpastatin, the endogenous inhibitor of calpains. In the present study, we investigated the function of calpain-1 in mature erythrocytes using our calpain-1-null [KO (knockout)] mouse model. The calpain-1 gene deletion results in improved erythrocyte deformability without any measurable effect on erythrocyte lifespan in vivo. The calcium-induced sphero-echinocyte shape transition is compromised in the KO erythrocytes. Erythrocyte membrane proteins ankyrin, band 3, protein 4.1R, adducin and dematin are degraded in the calcium-loaded normal erythrocytes but not in the KO erythrocytes. In contrast, the integrity of spectrin and its state of phosphorylation are not affected in the calcium-loaded erythrocytes of either genotype. To assess the functional consequences of attenuated cytoskeletal remodelling in the KO erythrocytes, the activity of major membrane transporters was measured. The activity of the K+-Cl- co-transporter and the Gardos channel was significantly reduced in the KO erythrocytes. Similarly, the basal activity of the calcium pump was reduced in the absence of calmodulin in the KO erythrocyte membrane. Interestingly, the calmodulin-stimulated calcium pump activity was significantly elevated in the KO erythrocytes, implying a wider range of pump regulation by calcium and calmodulin. Taken together, and with the atomic force microscopy of the skeletal network, the results of the present study provide the first evidence for the physiological function of calpain-1 in erythrocytes with therapeutic implications for calcium imbalance pathologies such as sickle cell disease.

